Process for preparing a pharmaceutical composition for use as an anti-arrhythmia drug with a controlled beta-adrenergic block, pharmaceutical composition, oral and parenteral preparation for the treatment of heart disease in mammals, and method of treatment for them

摘要

"PHARMACEUTICAL COMPOSITION FOR USE AS AN ANTIARRHYTHMIC MEDICINE WITH A CONTROLLED ADRENERGIC BETA BLOCK, ORAL AND PARENTERAL PREPARATION FOR TREATING MAMMALIAN HEART DISEASES AND TREATMENT METHOD FOR THE SAME". The invention describes a safer antiarrhythmic drug with a controlled beta-adrenergic activity that comprises a combination of sotalol dextro- and rotating levo-isomers as active ingredients in which the ratio of said dextro- and levo-isomers is 1, 5: 1 to 3.05: 1, pharmaceutical compositions with this combination as active ingredients and their preparation and use of this combination in the treatment of heart disease in mammals, including human beings.